We are live on ! Find out more
SRRA

Sierra Oncology, Inc. Common Stock
SRRA

Delisted

SRRA was delisted on the 30th of June, 2022.

Back to rankings

51 hedge funds and large institutions have $115M invested in Sierra Oncology, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

156% more capital invested

Capital invested by funds: $45M → $115M (+$70.4M)

111% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 9

24% more funds holding

Funds holding: 41 → 51 (+10)

13% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 8

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
51
Holders Change
+10
Holders Change %
+24.39%
% of All Funds
1.16%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
19
Increased
9
Reduced
8
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
+$3.23M
2
6CM
683 Capital Management
New York
+$2.21M
3
CS
Candriam SCA
Luxembourg
+$1.44M
4
SFM
Sphera Funds Management
Israel
+$1.32M
5
Renaissance Technologies
Renaissance Technologies
New York
+$996K

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$3M
2
DM
Deerfield Management
New York
-$2.5M
3
O
OrbiMed
New York
-$1.2M
4
SM
Sabby Management
Florida
-$827K
5
PAM
Panagora Asset Management
Massachusetts
-$308K
Name Holding Trade Value Shares
Change 		Change in
Stake
DS
26
DRW Securities
Illinois
$149K +$36K +375 +60%
Cambridge Investment Research Advisors
27
Cambridge Investment Research Advisors
Iowa
$144K +$92.9K +967 New
ASN
28
Advisory Services Network
Georgia
$139K – – –
Geode Capital Management
29
Geode Capital Management
Massachusetts
$131K – – –
Acadian Asset Management
30
Acadian Asset Management
Massachusetts
$121K +$41.2K +429 +112%
RJT
31
Raymond James Trust
Florida
$108K – – –
RC
32
RBF Capital
California
$93K – – –
Connor, Clark & Lunn Investment Management (CC&L)
33
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$92K +$30.6K +318 +106%
PNC Financial Services Group
34
PNC Financial Services Group
Pennsylvania
$87K – – –
Wells Fargo
35
Wells Fargo
California
$83K +$31.6K +329 +144%
COI
36
Connable Office Inc
Michigan
$59K – – –
MML Investors Services
37
MML Investors Services
Massachusetts
$52K +$33.6K +350 New
GC
38
Guggenheim Capital
Illinois
$50K -$4.04K -42 -11%
TAM
39
Tocqueville Asset Management
New York
$47K +$30.1K +313 New
VF
40
Virtu Financial
New York
$45K +$29.3K +305 New
Two Sigma Advisers
41
Two Sigma Advisers
New York
$43K +$27.9K +290 New
CSS
42
Cubist Systematic Strategies
Connecticut
$33K +$19.5K +203 +1,194%
CIBC Private Wealth Group
43
CIBC Private Wealth Group
Georgia
$27K +$17.1K +178 New
Parallax Volatility Advisers
44
Parallax Volatility Advisers
California
$25K – – –
Macquarie Group
45
Macquarie Group
Australia
$10K +$6.25K +65 New
Barclays
46
Barclays
United Kingdom
$7K +$4.23K +44 New
Morgan Stanley
47
Morgan Stanley
New York
$7K +$4.81K +50 New
TRCT
48
Tower Research Capital (TRC)
New York
$5K +$3.27K +34 New
Royal Bank of Canada
49
Royal Bank of Canada
Ontario, Canada
$4K -$577 -6 -18%
RE
50
RBC Europe
United Kingdom
$3.64K – – –
1
2
3

SRRA Hedge Fund Activity: Q4 2017 in Review

51 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Sierra Oncology, Inc. Common Stock (SRRA) for Q4 2017, worth a combined $115M — up 156% from $45M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new SRRA positions and 9 closed out — a net gain of 10 holders — while 9 added to existing stakes and 8 trimmed.

The largest buyer was Perceptive Advisors, adding an estimated $3.23M. The largest seller was Point72 Asset Management, cutting an estimated $3M.

  • 51 institutional investors held Sierra Oncology, Inc. Common Stock (SRRA) as of Q4 2017, up from 41 in Q3 2017.
  • Funds reported $115M of Sierra Oncology, Inc. Common Stock stock for Q4 2017, up 156% quarter-over-quarter.
  • 19 funds opened new Sierra Oncology, Inc. Common Stock positions in Q4 2017 and 9 closed out, a net change of +10 holders.
  • The largest Sierra Oncology, Inc. Common Stock buyer in Q4 2017 was Perceptive Advisors, an estimated $3.23M added.
  • The largest Sierra Oncology, Inc. Common Stock seller in Q4 2017 was Point72 Asset Management, an estimated $3M sold.

Based on aggregated 13F filings for Q4 2017.